Your browser doesn't support javascript.
loading
Research ethics and public trust in vaccines: the case of COVID-19 challenge trials.
Eyal, Nir.
Afiliação
  • Eyal N; Center for Population-Level Bioethics, Department of Philosophy (SAS) and Department of HBSP (SPH), Rutgers University, New Brunswick, New Jersey, USA nir.eyal@rutgers.edu.
J Med Ethics ; 2022 May 20.
Article em En | MEDLINE | ID: mdl-35595525
ABSTRACT
Despite their clearly demonstrated safety and effectiveness, approved vaccines against COVID-19 are commonly mistrusted. Nations should find and implement effective ways to boost vaccine confidence. But the implications for ethical vaccine development are less straightforward than some have assumed. Opponents of COVID-19 vaccine challenge trials, in particular, made speculative or empirically implausible warnings on this matter, some of which, if applied consistently, would have ruled out most COVID-19 vaccine trials and many non-pharmaceutical responses.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: J Med Ethics Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: J Med Ethics Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos